Analgesics
Antiandrogens
Antihistamines
Budesonide
Colchicine
Conv. Plasma
Curcumin
Fluvoxamine
Hydroxychlor..
Ivermectin
Lifestyle
Melatonin
Metformin
Minerals
Monoclonals
Mpro inhibitors
Naso/orophar..
Nigella Sativa
Nitazoxanide
PPIs
Quercetin
RdRp inhibitors
TMPRSS2 inh.
Thermotherapy
Vitamins
More

Other
Feedback
Home
 
next
study
previous
study
c19early.org COVID-19 treatment researchVitamin DVitamin D (more..)
Budesonide Meta
Colchicine Meta Nigella Sativa Meta
Conv. Plasma Meta Nitazoxanide Meta
Curcumin Meta PPIs Meta
Fluvoxamine Meta Quercetin Meta
Hydroxychlor.. Meta
Ivermectin Meta
Thermotherapy Meta
Melatonin Meta
Metformin Meta

 

Association between vitamin D and COVID-19 infection and mortality in Taiwanese patients

Sheng et al., Journal of the Chinese Medical Association, doi:10.1097/JCMA.0000000000001294, Sep 2025
https://c19early.org/sheng2.html
Mortality 91% Improvement Relative Risk Vitamin D for COVID-19  Sheng et al.  Sufficiency Are vitamin D levels associated with COVID-19 outcomes? Retrospective 67 patients in Taiwan Lower mortality with higher vitamin D levels (p=0.035) c19early.org Sheng et al., J. the Chinese Medical A.., Sep 2025 Favorsvitamin D Favorscontrol 0 0.5 1 1.5 2+
Vitamin D for COVID-19
8th treatment shown to reduce risk in October 2020, now with p < 0.00000000001 from 126 studies, recognized in 18 countries.
No treatment is 100% effective. Protocols combine treatments.
6,100+ studies for 180 treatments. c19early.org
Retrospective 481 symptomatic adults in Taiwan showing higher mortality among COVID-19-positive patients with vitamin D deficiency. There was no crude association between vitamin D level and infection risk, however infection was analyzed univariately using vitamin D as a continuous variable only. Multivariable analysis was only done for mortality.
This is the 223rd of 224 COVID-19 sufficiency studies for vitamin D, which collectively show higher levels reduce risk with p<0.0000000001 (1 in 18,005,498,199,331,485,696 vigintillion).
risk of death, 90.6% lower, OR 0.09, p = 0.04, high D levels (≥30 ng/mL) 22, low D levels (<20 ng/mL) 45, adjusted per study, inverted to make OR<1 favor high D levels (≥30 ng/mL), multivariable, RR approximated with OR.
Effect extraction follows pre-specified rules prioritizing more serious outcomes. Submit updates
Sheng et al., 12 Sep 2025, retrospective, Taiwan, peer-reviewed, mean age 58.2, 6 authors. Contact: shchiu2@vghtpe.gov.tw, hyhuang21@vghtpe.gov.tw.
Association between vitamin D and COVID-19 infection and mortality in Taiwanese patients
Ching-Ching Sheng, Shuan-Yi Su, Ying Liang, Hui-Chuan Cheng, Hsin-Yi Huang, correspondence. Rn Hsiao-Hui Chiu
Journal of the Chinese Medical Association, doi:10.1097/jcma.0000000000001294
Background: Vitamin D plays a role in immune regulation and may influence COVID-19 outcomes. This study examined the association between serum vitamin D levels with COVID-19 infection and mortality in symptomatic patients in Taiwan. Methods: This retrospective cohort study included symptomatic patients who underwent COVID-19 real-time polymerase chain reaction (RT-PCR) assay between 2020 and 2023. Serum 25-hydroxyvitamin D (25(OH)D) levels were categorized as deficient (<20 ng/mL), insufficient (20-30 ng/mL), or sufficient (≥30 ng/mL). Logistic regression models were used to evaluate the impact of vitamin D levels on COVID-19 infection and mortality, adjusting for potential confounders including age, sex, and comorbidities. Results: Among the 481 participants (mean age 58.2 years; 66.7% female), 96 (19.96%) tested positive for COVID-19. Vitamin D level was not associated with COVID-19 infection (OR=1.00, 95% CI: 0.99-1.02, p=0.687), however vitamin D deficiency significantly increased the risk of COVID-19-related mortality (OR=10.68, 95% CI: 1.18-96.45; p=0.035). The mortality rate in patients aged 65-74 years was higher compared to those aged 19-44 years (OR=12.91, 95% CI: 1.29-128.83; p=0.029). Conclusions: Vitamin D levels were not associated with susceptibility to COVID-19 infection. However, vitamin D deficiency, particularly in older patients, was associated with an increased risk of mortality among those diagnosed with COVID-19. These findings support the role of vitamin D in reducing COVID-19 mortality, and emphasize the importance of maintaining sufficient levels in high-risk populations.
References
Alguwaihes, Sabico, Hasanato, Me, Megdad et al., Severe vitamin d deficiency is not related to sars-cov-2 infection but may increase mortality risk in hospitalized adults: a retrospective case-control study in an arab gulf country, Aging Clin Exp Res
Aranow, Vitamin D and the immune system, J Investig Med
Athanassiou, Kostoglou-Athanassiou, Nikolakopoulou, Konstantinou, Mascha et al., Vitamin D levels as a marker of severe SARS-CoV-2 infection, Life
Bassatne, Basbous, Chakhtoura, El Zein, Rahme et al., The link between COVID-19 and vitamin d (vivid): a systematic review and meta-analysis, Metabolism
Bianconi, Mannarino, Figorilli, Cosentini, Batori et al., Prevalence of vitamin d deficiency and its prognostic impact on patients hospitalized with COVID-19, Nutrition
Chiodini, Gatti, Soranna, Merlotti, Mingiano et al., Vitamin D status and sars-cov-2 infection and COVID-19 clinical outcomes, Front Public Health
Fantini, Corinaldesi, Lenzi, Migliaccio, Crescioli, Vitamin D as a shield against aging, International Journal of Molecular Sciences
Gibson-Moore, Vitamin D: What's new a year on from the COVID-19 outbreak?, Nutr Bull
Hafezi, Sharif-Askari, Sharif-Askari, Hussain Alsayed, Alsafar et al., Vitamin D enhances type i ifn signaling in COVID-19 patients, Sci Rep
Ismailova, White, Vitamin D, infections and immunity, Rev Endocr Metab Disord
Katz, Yue, Xue, Increased risk for COVID-19 in patients with vitamin D deficiency, Nutrition
Kaya, Pamukçu, Yakar, The role of vitamin d deficiency on COVID-19: A systematic review and meta-analysis of observational studies, Epidemiol Health
Malaguarnera, Vitamin D3 as potential treatment adjuncts for COVID-19, Nutrients
Mistry, Barmania, Mellet, Peta, Strydom et al., SARS-CoV-2 variants, vaccines, and host immunity, Front Immunol
Shah, Varna, Sharma, Mavalankar, Does vitamin D supplementation reduce COVID-19 severity?: A systematic review, Qjm
Smaha, Kužma, Jackuliak, Nachtmann, Max et al., Serum 25hydroxyvitamin D concentration significantly decreases in patients with COVID-19 pneumonia during the first 48 hours after hospital admission, Nutrients
Znaidia, Demeret, Van Der Werf, Komarova, Characterization of SARS-CoV-2 evasion: Interferon pathway and therapeutic options, Viruses
DOI record: { "DOI": "10.1097/jcma.0000000000001294", "ISSN": [ "1726-4901" ], "URL": "http://dx.doi.org/10.1097/JCMA.0000000000001294", "abstract": "<jats:sec>\n <jats:title>Background:</jats:title>\n <jats:p>Vitamin D plays a role in immune regulation and may influence COVID-19 outcomes. This study examined the association between serum vitamin D levels with COVID-19 infection and mortality in symptomatic patients in Taiwan.</jats:p>\n </jats:sec>\n <jats:sec>\n <jats:title>Methods:</jats:title>\n <jats:p>This retrospective cohort study included symptomatic patients who underwent COVID-19 real-time polymerase chain reaction (RT-PCR) assay between 2020 and 2023. Serum 25-hydroxyvitamin D (25(OH)D) levels were categorized as deficient (&lt;20 ng/mL), insufficient (20–30 ng/mL), or sufficient (≥30 ng/mL). Logistic regression models were used to evaluate the impact of vitamin D levels on COVID-19 infection and mortality, adjusting for potential confounders including age, sex, and comorbidities.</jats:p>\n </jats:sec>\n <jats:sec>\n <jats:title>Results:</jats:title>\n <jats:p>Among the 481 participants (mean age 58.2 years; 66.7% female), 96 (19.96%) tested positive for COVID-19. Vitamin D level was not associated with COVID-19 infection (OR=1.00, 95% CI: 0.99–1.02, <jats:italic toggle=\"yes\">p</jats:italic>=0.687), however vitamin D deficiency significantly increased the risk of COVID-19-related mortality (OR=10.68, 95% CI: 1.18–96.45; <jats:italic toggle=\"yes\">p</jats:italic>=0.035). The mortality rate in patients aged 65–74 years was higher compared to those aged 19–44 years (OR=12.91, 95% CI: 1.29–128.83; <jats:italic toggle=\"yes\">p</jats:italic>=0.029).</jats:p>\n </jats:sec>\n <jats:sec>\n <jats:title>Conclusions:</jats:title>\n <jats:p>Vitamin D levels were not associated with susceptibility to COVID-19 infection. However, vitamin D deficiency, particularly in older patients, was associated with an increased risk of mortality among those diagnosed with COVID-19. These findings support the role of vitamin D in reducing COVID-19 mortality, and emphasize the importance of maintaining sufficient levels in high-risk populations.</jats:p>\n </jats:sec>", "author": [ { "affiliation": [ { "name": "Department of Nursing, Taipei Veterans General Hospital, Taipei, Taiwan, ROC" }, { "name": "Department of Nursing, Chang Jung Christian University, Tainan, Taiwan, ROC" } ], "family": "Sheng", "given": "Ching-Ching", "sequence": "first" }, { "affiliation": [ { "name": "Department of Nursing, Taipei Veterans General Hospital, Taipei, Taiwan, ROC" } ], "family": "Su", "given": "Shuan-Yi", "sequence": "additional" }, { "affiliation": [ { "name": "Department of Nursing, Taipei Veterans General Hospital, Taipei, Taiwan, ROC" } ], "family": "Liang", "given": "Ying", "sequence": "additional" }, { "affiliation": [ { "name": "Department of Nursing, Taipei Veterans General Hospital, Taipei, Taiwan, ROC" } ], "family": "Cheng", "given": "Hui-Chuan", "sequence": "additional" }, { "affiliation": [ { "name": "Department of Information Management, Taipei Veterans General Hospital, Taipei, Taiwan, ROC" } ], "family": "Huang", "given": "Hsin-Yi", "sequence": "additional" }, { "affiliation": [ { "name": "Department of Nursing, Taipei Veterans General Hospital, Taipei, Taiwan, ROC" }, { "name": "Department of Nursing, National Taipei University of Nursing and Health Sciences, Taipei, Taiwan, ROC" }, { "name": "School of Nursing, National Defense Medical Center, Taipei, Taiwan, ROC" } ], "family": "Chiu", "given": "Hsiao-Hui", "sequence": "additional" } ], "container-title": "Journal of the Chinese Medical Association", "content-domain": { "crossmark-restriction": true, "domain": [ "lww.com", "ovid.com" ] }, "created": { "date-parts": [ [ 2025, 9, 12 ] ], "date-time": "2025-09-12T11:01:19Z", "timestamp": 1757674879000 }, "deposited": { "date-parts": [ [ 2025, 9, 12 ] ], "date-time": "2025-09-12T11:01:20Z", "timestamp": 1757674880000 }, "indexed": { "date-parts": [ [ 2025, 9, 12 ] ], "date-time": "2025-09-12T15:44:09Z", "timestamp": 1757691849531, "version": "3.44.0" }, "is-referenced-by-count": 0, "issued": { "date-parts": [ [ 2025, 9, 12 ] ] }, "language": "en", "link": [ { "URL": "https://journals.lww.com/10.1097/JCMA.0000000000001294", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking" } ], "member": "276", "original-title": [], "prefix": "10.1097", "published": { "date-parts": [ [ 2025, 9, 12 ] ] }, "published-online": { "date-parts": [ [ 2025, 9, 12 ] ] }, "publisher": "Ovid Technologies (Wolters Kluwer Health)", "reference-count": 0, "references-count": 0, "relation": {}, "resource": { "primary": { "URL": "https://journals.lww.com/10.1097/JCMA.0000000000001294" } }, "score": 1, "short-title": [], "source": "Crossref", "subject": [], "subtitle": [], "title": "Association between vitamin D and COVID-19 infection and mortality in Taiwanese patients", "type": "journal-article", "update-policy": "https://doi.org/10.1097/lww.0000000000001000" }
Loading..
Please send us corrections, updates, or comments. c19early involves the extraction of 200,000+ datapoints from thousands of papers. Community updates help ensure high accuracy. Treatments and other interventions are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. IMA and WCH provide treatment protocols.
  or use drag and drop   
Submit